ARTICLE | Clinical News
Alista alprostadil regulatory update
October 8, 2001 7:00 AM UTC
VVUS received U.S. Patent No. 6,294,550 covering the treatment of female sexual dysfunction using vasoactive agents. The patent relates to VVUS's Alista, which is in Phase II testing. ...